| back to VIM antibodies | | | This is a review about vimentin antibodies, based on 30 published articles using vimentin antibodies in western blot, immunohistochemistry, immunoprecipitation, immunocytochemistry, and other immunological technologies. It is aimed to help ExactAntigen visitors find the most suited vimentin antibody. Information in this review (with links to publications) can be searched freely. |
SIGMA search SIGMA VIM products
Other Brands or Spellings: SIGMA-ALDRICH, SIGMA CHEMICAL, SIGMA CHEMICAL COMPANY, SIGMA-ALDRICH FINE CHEMICALS
| | ic, wb | | Sigma mouse anti-human monoclonal vimentin antibody (V6630) was used in western blot and immunocytochemistry to study transforming growth factor-beta responses in smooth muscle cell | | ic | | Sigma monoclonal anti-vimentin antibody V9 was used in immunocytochemistry to study sialomucin complex (rat Muc4) and receptor tyrosine kinase ErbBs in the rat lacrimal gland | | ic | | Sigma mouse anti-vimentin monoclonal antibody (clone V9) was used in immunocytochemistry to detect the effects of hNFL mutations on co-assembly with vimentin in SW13 Vim+ human adrenal carcinoma cells | | ic | | Sigma anti-vimentin antibody was used in New Zealand white rabbits renal proximal tubular cell(RPTCs,which were infected with recombinant adenovirus expressing kinase inactive form of human p38) and in immunocytochemistry to study the role for the effect of p38 kinase on transactivation of the epidermal growth factor receptor in dedifferentiation of renal epithelial cells after oxidant injury | | ic | | Sigma anti-vimentin antibody was used in african monkey kidney cell line COS-7 with human wild type alpha-syn cDNA and in immunocytochemistry to study the effects of inhibitors of the mitochondrial electron-transport chain on the aggregation of -synuclein | | ic | | Sigma monoclonal anti-vimentin antibody clone V9 (1:100)was used in immunofluorescence as a marker of the intermediate filament network to study the redistribution of vimentin in cells expressing mutant ELOVL4 | | ih | | Sigma vimentin monoclonal antibody was used in immunohistochemistry to study human placentation |
| SANTA CRUZ BIOTECHNOLOGY search SANTA CRUZ BIOTECHNOLOGY VIM products
Other Brands or Spellings: SANTA CRUZ, SANTA CRUZ BIOTECH, SANTA CRUZ BIOTECHNOLOGY INC., SANTA CRUZ BIOTECHNOLOGY INC, SANTZ CRUZ, SANTA CRUZ BIOTECHNOLOGIES
| | ic, wb | | Santa Cruz anti-vimentin antibody was used in human HMEC-1 cells and C166 cells and in immunocytochemistry,western blot to study the role of DP in capillary formation/stabilization | | ih | | Santa Cruz Biotechnology affinity-purified polyclonal vimentin antibody was used in immunohistochemistry to study integrin-dependent NOV (CCN3) functions in wound healing |
| DAKO
Other Brands or Spellings: DAKOCYTOMATION, DAKO CYTOMATION, DAKO DIAGNOSTIC, DAKO CORP, DAKO CORPORATION, DAKO CORP., DAKO DIAGNOSTICS, DAKO A/S, DAKO DIAGNOSTIKA, DAKO LABORATORIES, DAKO-CYTOMATION, DAKO A/F, DAKOPATTS
| | ic | | Dako antibody to vimentin (clone V9) was used in immunocytochemistry to investigate the expression and regulation of growth-regulated oncogene alpha in human endometrial stromal cells | | ic | | Dako anti-vimentin antibody was used in human Kaposi's sarcoma cells (KS cells) and in immunocytochemistry to study the molecular mechanisms through which HIV-1-Tat protein inhibits vincristine-induced apoptosis of KS cells | | ic | | DAKO vimentin antibody was used in immunocytochemistry to study cardiotrophin-1 effect on cardiac fibroblast growth | | ic | | DAKO anti-vimentin antibody was used in immunocytochemistry to study the relationship between FPR expression and the biologic behavior of glioma cells | | ic | | Dako mouse monoclonal antivimentin antibody (clone V9) was used in immunocytochemistry to study the possible correlation of the antitumor activity of fibroblast growth factors (FGFs) for medulloblastoma with FGF receptor expression and tumor variant | | ih | | DakoCytomation VIM antibody was tested in immunohistochemistry by HPA (HPA001762) | | ih | | DAKO anti-Vimentin antibody was used in immunohistochemistry to study the clinical and experimental progression of a new model of human prostate cancer and therapeutic approach | | ih | | DAKO mouse monoclonal anti-vimentin antibody was used in immunohistochemistry to localize amnion mesenchymal cells in human placental tissue | | ih | | Dako Diagnostics mouse vimentin antibody (M7020) was used in immunohistochemistry to study activation of enteric neurons and enteric glia in the guinea pig ileum and colon by IL1B | | ih | | Dako mouse anti-human vimentin mAb (clone V9, IgG1) was used in immunohistochemistry to study the acquisition of a chemokine receptor named CCR1 as trophoblasts differentiate towards invasive phenotype | | ih | | DAKO anti-vimentin antibody was used in immunohistochemistry to identify a series of genetic events leading to translocation, deletion/amplification, and overexpression of the HMGIC and MDM2 genes in a carcinoma ex pleomorphic adenoma (CexPA) at an early stage of development | | ih | | Dako vimentin antibody was used in immunohistochemistry to study SFTPC gene mutation in an interstitial lung disease patient | | wb | | Dako vimentin monoclonal antibody was used in western blot to study the interaction between hamartin and neurofilament-L |
| ZYMED search ZYMED VIM products
Other Brands or Spellings: INVITROGEN, BIOSOURCE, BIOSOURCE INTERNATIONAL, ZYMED LABORATORIES, CALTAG, MOLECULAR PROBES, MEDGENIX DIAGNOSTICS, MEDGENIX, DYNAL ASA, CALTAG LABORATORIES, RESEARCH GENETICS, ZYMED LABORATORIES INC.
| | ic | | Zymed anti-Vimentin antibody was used in immunocytochemistry to study the role of Ciliary neurotrophic factor (CNTF) to induce the dedifferenciation of adult human myoblasts via p44/p42 MAPK pathway in vitro | | ih | | Zymed anti-vimentin antibody was used in immunohistochemistry to study primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma |
| BIOGENEX LABORATORIES
| | ih | | BioGenex Laboratories anti-vimentin antibody was used in immunohistochemistry to study the down-regulation of iNOS expression by MDA-7 in melanoma cells | | ih | | BioGenex Laboratories antivimentin antibodies were used in immunohistochemistry to study the loss of MDA-7 expression with progression of melanoma |
| PROGEN
| | ic | | Progen mouse monoclonal anti-vimentin antibody was used in immunocytochemistry to study MRP2 mutation |
| PROGEN BIOTECHNIK
| | ic | | Progen Biotechnik FITC-conjugated mouse anti-human vimentin mAb (clone 3B4, IgG2a) was used in immunocytochemistry to study the acquisition of a chemokine receptor named CCR1 as trophoblasts differentiate towards invasive phenotype |
| LAB VISION
Other Brands or Spellings: LABVISION, NEOMARKERS, NEOMARKER, LAB VISION/NEOMARKERS
| | wb | | Lab Vision Vimentin Ab-2 antibody was tested in western blot by Abminer |
| ROCHE MOLECULAR BIOCHEMICALS
Other Brands or Spellings: ROCHE APPLIED SCIENCE, ROCHE DIAGNOSTICS
| | ic | | Roche Molecular Biochemicals monoclonal antibody directed against vimentin was used in immunocytochemistry to provide the first evidence that the tumor suppressor nm23-H2 could act on beta1 integrin-mediated cell adhesion by interacting with one of the integrin partners ICAP-1alpha |
| ATLAS ANTIBODIES
| | ih | | Atlas Antibodies VIM antibody was tested in immunohistochemistry by HPA (HPA001762) |
| BECKMAN COULTER
Other Brands or Spellings: IMMUNOTECH, IMMUNOTECH-COULTER, IMMUNOTECH INTERNATIONAL, COULTER-IMMUNOTECH, COULTER IMMUNOTECH
| | ih | | Beckman Coulter mouse monoclonal anti-vimentin antibody V9 was used in immunohistochemistry to study the expression of putative LMX1B in nail-patella syndrome kidneys |
|
Articles Reviewed | | 1. P Argani et al. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents. 2001 | | 2. K Nasu et al. Expression and regulation of growth-regulated oncogene alpha in human endometrial stromal cells. 2001 | | 3. G de Pinieux et al. Clinical and experimental progression of a new model of human prostate cancer and therapeutic approach. 2001 | | 4. M E Arango et al. Production and localization of Muc4/sialomucin complex and its receptor tyrosine kinase ErbB2 in the rat lacrimal gland. 2001 | | 5. He-Jin Lee et al. Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors. 2002 | | 6. Sabine M Duplan et al. Antitumor activity of fibroblast growth factors (FGFs) for medulloblastoma may correlate with FGF receptor expression and tumor variant. 2002 | | 7. Toshihiro Tsuruda et al. Cardiotrophin-1 stimulation of cardiac fibroblast growth: roles for glycoprotein 130/leukemia inhibitory factor receptor and the endothelin type A receptor. 2002 | | 8. Eva Röijer et al. Translocation, deletion/amplification, and expression of HMGIC and MDM2 in a carcinoma ex pleomorphic adenoma. 2002 | | 9. Julie A Ellerhorst et al. Loss of MDA-7 expression with progression of melanoma. 2002 | | 10. Henri-Noël Fournier et al. Integrin cytoplasmic domain-associated protein 1alpha (ICAP-1alpha ) interacts directly with the metastasis suppressor nm23-H2, and both proteins are targeted to newly formed cell adhesion sites upon integrin engagement. 2002 | | 11. Maria Chiara Deregibus et al. HIV-1-Tat protein activates phosphatidylinositol 3-kinase/ AKT-dependent survival pathways in Kaposi's sarcoma cells. 2002 | | 12. Xiaojuan Yan et al. Nuclear factor kappa B activation and regulation of cyclooxygenase type-2 expression in human amnion mesenchymal cells by interleukin-1beta. 2002 | | 13. Luciana A Haddad et al. The TSC1 tumor suppressor hamartin interacts with neurofilament-L and possibly functions as a novel integrator of the neuronal cytoskeleton. 2002 | | 14. Verena Keitel et al. A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2). 2003 | | 15. Raul Perez-Olle et al. Effects of Charcot-Marie-Tooth-linked mutations of the neurofilament light subunit on intermediate filament formation. 2002 | | 16. Suhendan Ekmekcioglu et al. Negative association of melanoma differentiation-associated gene (mda-7) and inducible nitric oxide synthase (iNOS) in human melanoma: MDA-7 regulates iNOS expression in melanoma cells. 2003 | | 17. Rachel C Chambers et al. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. 2003 | | 18. Laurence Heidet et al. In vivo expression of putative LMX1B targets in nail-patella syndrome kidneys. 2003 | | 19. Eric T T L Tjwa et al. Interleukin-1beta activates specific populations of enteric neurons and enteric glia in the guinea pig ileum and colon. 2003 | | 20. Hideki Koi et al. Thrombin receptors and protease-activated receptor-2 in human placentation: receptor activation mediates extravillous trophoblast invasion in vitro. 2003 | | 21. Yukiyasu Sato et al. Trophoblasts acquire a chemokine receptor, CCR1, as they differentiate towards invasive phenotype. 2003 | | 22. Xuan Zhou et al. Desmoplakin is required for microvascular tube formation in culture. 2004 | | 23. F Brasch et al. Interstitial lung disease in a baby with a de novo mutation in the SFTPC gene. 2004 | | 24. Cristiane G Lin et al. Integrin-dependent functions of the angiogenic inducer NOV (CCN3): implication in wound healing. 2005 | | 25. Shougang Zhuang et al. p38 kinase-mediated transactivation of the epidermal growth factor receptor is required for dedifferentiation of renal epithelial cells after oxidant injury. 2005 | | 26. Xiaoping Chen et al. Dedifferentiation of adult human myoblasts induced by ciliary neurotrophic factor in vitro. 2005 | | 27. Ye Zhou et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. 2005 | | 28. Celene Grayson et al. Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4. 2005 | | 29. Sylvia Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 | | 30. A Persson et al. A human protein atlas based on antibody proteomics. 2006 |
|